Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association

Duell, P. Barton, Welty, Francine K., Miller, Michael, Chait, Alan, Hammond, Gmerice, Ahmad, Zahid, Cohen, David E., Horton, Jay D., Pressman, Gregg S., Toth, Peter P., on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Lifestyle and Cardiometabolic Health; and Council on Peripheral Vascular Disease · 2022 · Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is believed to affect >25% of adults worldwide. Unless specific testing is done to identify NAFLD, the condition is typically silent until advanced and potentially irreversible liver impairment occurs. For this reason, the majority of patients with NAFLD are unaware of having this serious condition. Hepatic complications from NAFLD include nonalcoholic steatohepatitis, hepatic cirrhosis, and hepatocellular carcinoma. In addition to these serious complications, NAFLD is a risk factor for atherosclerotic cardiovascular disease, which is the principal cause of death in patients with NAFLD. Accordingly, the purpose of this scientific statement is to review the underlying risk factors and pathophysiology of NAFLD, the associations with atherosclerotic cardiovascular disease, diagnostic and screening strategies, and potential interventions.

Overview

Integrity signals

Registry

Crossref · 10.1161/atv.0000000000000153

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

16 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

1 retracted

Show all 157 references

Research works printed but not linked: 1

  1. Eaton, S, Sherratt, HSA, Pourfarzam, M, Quant, PA, Bartlett, K. Control of mitochondrial β-oxidation at the levels of [NAD+]/[NADH] and CoA acylation. Quant, PA, Eaton, S, eds. In: Current Views of Fatty Acid Oxidation and Ketogenesis. Springer; 2002.

Cited by

See all 727

Metadata

Authors
Duell, P. B., Welty, F. K., Miller, M., Chait, A., Hammond, G., Ahmad, Z., Cohen, D. E., Horton, J. D., Pressman, G. S., Toth, P. P., & on behalf of the American Heart Association Council on Arteriosclerosis, T. A. V. B. C. O. H. C. O. T. K. I. C. D. C. O. L. A. C. H. A. C. O. P. V. D.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2022-06
Volume
42
Issue
6
Pages
e168-e185
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W4224052225
Cited by
727
References
157
Citations by year
2026: 166 · 2025: 215 · 2024: 188 · 2023: 123 · 2022: 34
FWCI
22.24
Type
journal article
Language
en
Open access
closed
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
non-alcoholic fatty liver disease, cardiovascular risk, atherosclerotic cardiovascular disease, nonalcoholic steatohepatitis, liver cirrhosis, hepatocellular carcinoma, risk factors, pathophysiology, screening, diagnosis, intervention
MeSH terms
Heart Disease Risk Factors, Adult, American Heart Association, Cardiovascular Diseases, Humans, Liver, Risk Factors, Atherosclerosis, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/atv.0000000000000153
The paper
Duell, P. B., Welty, F. K., Miller, M., Chait, A., Hammond, G., Ahmad, Z., Cohen, D. E., Horton, J. D., Pressman, G. S., Toth, P. P., & on behalf of the American Heart Association Council on Arteriosclerosis, T. A. V. B. C. O. H. C. O. T. K. I. C. D. C. O. L. A. C. H. A. C. O. P. V. D. (2022). Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atv.0000000000000153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.